Nutra Pharma Corp Stock Buy Hold or Sell Recommendation

NPHC Stock  USD 0.0001  0.00  0.00%   
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Nutra Pharma Corp is 'Not Rated'. Macroaxis provides Nutra Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NPHC positions.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
In addition, we conduct extensive research on individual companies such as Nutra and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Nutra Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Execute Nutra Pharma Buy or Sell Advice

The Nutra recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nutra Pharma Corp. Macroaxis does not own or have any residual interests in Nutra Pharma Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nutra Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Nutra PharmaBuy Nutra Pharma
Not Rated
For the selected time horizon Nutra Pharma Corp has a Risk Adjusted Performance of 0.0861, Jensen Alpha of 1.43, Total Risk Alpha of (0.76) and Treynor Ratio of 2.24
We provide investment recommendation to complement the last-minute expert consensus on Nutra Pharma Corp. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Nutra Pharma Corp is not overpriced, please verify all Nutra Pharma Corp fundamentals, including its net income, target price, net asset, as well as the relationship between the current ratio and market capitalization . As Nutra Pharma Corp appears to be a penny stock we also strongly suggest to check its shares owned by institutions numbers.

Nutra Pharma Trading Alerts and Improvement Suggestions

Nutra Pharma Corp is not yet fully synchronised with the market data
Nutra Pharma Corp has some characteristics of a very speculative penny stock
Nutra Pharma Corp has a very high chance of going through financial distress in the upcoming years
Nutra Pharma Corp currently holds 517.18 K in liabilities. Nutra Pharma Corp has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutra Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Nutra Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutra Pharma Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutra to invest in growth at high rates of return. When we think about Nutra Pharma's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 51.9 K. Net Loss for the year was (769.18 K) with profit before overhead, payroll, taxes, and interest of 8.47 K.
Nutra Pharma Corp currently holds about 10.45 K in cash with (878.09 K) of positive cash flow from operations.

Nutra Pharma Returns Distribution Density

The distribution of Nutra Pharma's historical returns is an attempt to chart the uncertainty of Nutra Pharma's future price movements. The chart of the probability distribution of Nutra Pharma daily returns describes the distribution of returns around its average expected value. We use Nutra Pharma Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nutra Pharma returns is essential to provide solid investment advice for Nutra Pharma.
Mean Return
1.52
Value At Risk
0.00
Potential Upside
0.00
Standard Deviation
15.11
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nutra Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Nutra Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nutra . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Nutra Pharma Buy or Sell Advice

When is the right time to buy or sell Nutra Pharma Corp? Buying financial instruments such as Nutra Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Nutra Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Warren Buffett Holdings Thematic Idea Now

Warren Buffett Holdings
Warren Buffett Holdings Theme
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Nutra Pink Sheet

Nutra Pharma financial ratios help investors to determine whether Nutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nutra with respect to the benefits of owning Nutra Pharma security.